These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 84471)

  • 1. Excretion of 5-s-cysteinyldopa in humans with genetically dark skin.
    Agrup G; Hansson C; Juldorf F; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1979; 59(1):69-70. PubMed ID: 84471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanocyte metabolites in the urine of people of different skin colour.
    Wirestrand LE; Hansson C; Rosengren E; Rorsman H
    Acta Derm Venereol; 1985; 65(4):345-8. PubMed ID: 2413694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of 5-S-cysteinyldopa in healthy Japanese.
    Morishima T; Hanawa S
    Acta Derm Venereol; 1981; 61(2):149-50. PubMed ID: 6165192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5 years' experience of 5-S-cysteinyldopa in melanoma diagnosis.
    Agrup G; Agrup P; Andersson T; Hafström L; Hansson C; Jacobsson S; Jönsson PE; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1979; 59(5):381-8. PubMed ID: 93360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of 5-S-cysteinyldopa is enhanced by PUVA and is independent of skin type.
    Tardy J; Barrois JP; Bendelac A; Leonard F; Triller R; Jardillier JC; Kalis B
    Photodermatol; 1987 Aug; 4(4):205-8. PubMed ID: 3124084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary free and conjugated 5-S-cysteinyldopa in normal subjects and in patients with melanoma.
    Graef V; Paul E
    Br J Dermatol; 1982 Jan; 106(1):53-7. PubMed ID: 6800394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seasonal variation in urinary excretion of 5-S-cysteinyldopa in healthy Japanese.
    Ito S; Kato T; Fujita K
    Acta Derm Venereol; 1987; 67(2):163-5. PubMed ID: 2438883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-S-cysteinyldopa excretion after treatment with 8-methoxypsoralen and UVA light.
    Agrup G; Hansson C; Rorsman H; Rosengren A-M ; Rosengren E; Tegner E
    J Invest Dermatol; 1978 Jan; 70(1):25-6. PubMed ID: 618976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of 6-hydroxy-5-methoxyindole-2-carboxylic acid and 5-S-cysteinyldopa during PUVA treatment.
    Hansson C; Wirestrand LE; Aronsson A; Rorsman H; Rosengren E
    Photodermatol; 1985 Apr; 2(2):52-7. PubMed ID: 3929237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-S-cysteinyldopa in the urine of melanoma patients.
    Agrup G; Agrup P; Andersson T; Falck B; Hansson JA; Jacobsson S; Rorsman H; Rosengren E; Rosengren AM
    Acta Derm Venereol; 1977; 57(2):113-6. PubMed ID: 71802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary excretion of melanocytic metabolites in fertile women.
    Carstam R; Hansson C; Rorsman H; Rosengren E; Sjöberg NO; Wirestrand LE
    Acta Derm Venereol; 1985; 65(6):543-5. PubMed ID: 2420122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of 5-S-cysteinyldopa in relation to skin type, UVB-induced erythema, and melanocyte proliferation in human skin.
    Stierner U; Rosdahl I; Augustsson A; Kågedal B
    J Invest Dermatol; 1988 Nov; 91(5):506-10. PubMed ID: 3139773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
    Stewart RM; Miller S; Gunder M
    Acta Derm Venereol; 1983; 63(2):97-101. PubMed ID: 6189350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative studies between excretion of 5-S-cysteinyldopa and indole melanogens in urine].
    Beyer C; Fiedler H; Wohlrab W; Wozniak KD
    Dermatol Monatsschr; 1986; 172(9):541-4. PubMed ID: 3098590
    [No Abstract]   [Full Text] [Related]  

  • 15. [5-S-cysteinyldopa in the urine - a "tumor test" for malignant melanoma? Comparison with the usual laboratory examinations].
    Paul E; Graef V; Ruppel R
    Z Hautkr; 1980 Dec; 55(23):1543-60. PubMed ID: 6782780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [5-S-cysteinyldopa determination in the urine. Its value for monitoring in melanoma patients].
    Paul E; Graef V; Ruppel R; Hellwich M
    Z Hautkr; 1983 Feb; 58(4):262-5. PubMed ID: 6405551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and quantitation of 5-S-cysteinyldopa in melanotic and amelanotic melanoma in comparison with nonpigment cell tumors and it's urinary excretion.
    Mojamdar M; Ichihashi M; Mishima Y
    J Dermatol; 1979 Dec; 6(6):379-82. PubMed ID: 120380
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of urinary 5-S-cysteinyldopa by high-performance liquid chromatography.
    Kågedal B; Pettersson A
    J Chromatogr; 1983 Feb; 272(2):287-97. PubMed ID: 6403561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UVB-induced melanocyte proliferation and 5-S-cysteinyldopa excretion in dysplastic nevus syndrome.
    Stierner U; Augustsson A; Rosdahl I; Kågedal B; Suurküla M
    Photodermatol; 1988 Oct; 5(5):218-23. PubMed ID: 3146749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Excretion of 5-S-cysteinyldopa in the urine of Japanese patients with malignant melanoma--a helpful biochemical marker for assessing the progression of disease].
    Hanawa S
    Nihon Hifuka Gakkai Zasshi; 1983 Mar; 93(4):433-42. PubMed ID: 6411952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.